CanadianKid
New member
FDA set to accept cloned animals for meat
By Rick Weiss
updated 1 hour, 8 minutes ago
A long-awaited final report from the Food and Drug Administration concludes that foods from healthy cloned animals and their offspring are as safe as those from ordinary animals, effectively removing the last U.S. regulatory barrier to the marketing of meat and milk from cloned cattle, pigs and goats.
The 968-page "final risk assessment," not yet released but obtained by The Washington Post, finds no evidence to support opponents' concerns that food from clones may harbor hidden risks.
But, recognizing that a majority of consumers are wary of food from clones -- and that cloning could undermine the wholesome image of American milk and meat -- the agency report includes hundreds of pages of raw data so that others can see how it came to its conclusions.
Story continues below ↓
--------------------------------------------------------------------------------
advertisement
--------------------------------------------------------------------------------
The report also acknowledges that human health concerns are not the only issues raised by the emergence of cloned farm animals.
"Moral, religious and ethical concerns . . . have been raised," the agency notes in a document accompanying the report. But the risk assessment is "strictly a science-based evaluation," it reports, because the agency is not authorized by law to consider those issues.
In practice, it will be years before foods from clones make their way to store shelves in appreciable quantities, in part because the clones themselves are too valuable to slaughter or milk. Instead, the pricey animals -- replicas of some of the finest farm animals ever born -- will be used primarily as breeding stock to create what proponents say will be a new generation of superior farm animals.
When food from those animals hits the market, the public may yet have its say. FDA officials have said they do not expect to require food from clones to be labeled as such, but they may allow foods from ordinary animals to be labeled as not from clones.
Opponents express dismay
Opponents of the approval, including some concerned about the welfare of the clones themselves, expressed dismay upon learning about the FDA's intentions.
Joseph Mendelson, legal director of the Center for Food Safety, a Washington advocacy group that petitioned FDA to restrict the sale of food from clones, said his group is considering legal action.
"One of the amazing things about this," Mendelson said, "is that at a time when we have a readily acknowledged crisis in our food safety system, the FDA is spending its resources and energy and political capital on releasing a safety assessment for something that no one but a handful of companies wants."
Take our online poll
Would you eat cloned meat?
Others countered that public opinion and politics should play no bigger role in the decision on clones than it should in the approval of a drug or a contraceptive.
"In fact, cloned animals have been studied much more than naturally produced animals," said Cindy Tian, who has analyzed milk and meat from clones at the University of Connecticut. "We have more data on them than for any other animal that we eat."
Release of the analysis was slowed for years by several forces, including the dairy industry, concerned about the potential impact on exports of U.S. whey solids, foreign sales of which are growing for use as a protein supplement.
In the past month, as an announcement neared, members of Congress, led by Sen. Barbara A. Mikulski (D-Md.), sought to delay approval through legislation.
Trade-related agencies including the Foreign Agricultural Service and the Office of the U.S. Trade Representative, which for years have struggled to get countries to accept U.S. gene-altered crops, also raised red flags.
A final blitz of meetings with FDA officials last week brought grudging acquiescence, insiders said. And it is possible, sources said, that even after the risk analysis is released, there will be calls for farmers to voluntarily refrain from selling products from clones until the trade issues can be resolved.
By Rick Weiss
updated 1 hour, 8 minutes ago
A long-awaited final report from the Food and Drug Administration concludes that foods from healthy cloned animals and their offspring are as safe as those from ordinary animals, effectively removing the last U.S. regulatory barrier to the marketing of meat and milk from cloned cattle, pigs and goats.
The 968-page "final risk assessment," not yet released but obtained by The Washington Post, finds no evidence to support opponents' concerns that food from clones may harbor hidden risks.
But, recognizing that a majority of consumers are wary of food from clones -- and that cloning could undermine the wholesome image of American milk and meat -- the agency report includes hundreds of pages of raw data so that others can see how it came to its conclusions.
Story continues below ↓
--------------------------------------------------------------------------------
advertisement
--------------------------------------------------------------------------------
The report also acknowledges that human health concerns are not the only issues raised by the emergence of cloned farm animals.
"Moral, religious and ethical concerns . . . have been raised," the agency notes in a document accompanying the report. But the risk assessment is "strictly a science-based evaluation," it reports, because the agency is not authorized by law to consider those issues.
In practice, it will be years before foods from clones make their way to store shelves in appreciable quantities, in part because the clones themselves are too valuable to slaughter or milk. Instead, the pricey animals -- replicas of some of the finest farm animals ever born -- will be used primarily as breeding stock to create what proponents say will be a new generation of superior farm animals.
When food from those animals hits the market, the public may yet have its say. FDA officials have said they do not expect to require food from clones to be labeled as such, but they may allow foods from ordinary animals to be labeled as not from clones.
Opponents express dismay
Opponents of the approval, including some concerned about the welfare of the clones themselves, expressed dismay upon learning about the FDA's intentions.
Joseph Mendelson, legal director of the Center for Food Safety, a Washington advocacy group that petitioned FDA to restrict the sale of food from clones, said his group is considering legal action.
"One of the amazing things about this," Mendelson said, "is that at a time when we have a readily acknowledged crisis in our food safety system, the FDA is spending its resources and energy and political capital on releasing a safety assessment for something that no one but a handful of companies wants."
Take our online poll
Would you eat cloned meat?
Others countered that public opinion and politics should play no bigger role in the decision on clones than it should in the approval of a drug or a contraceptive.
"In fact, cloned animals have been studied much more than naturally produced animals," said Cindy Tian, who has analyzed milk and meat from clones at the University of Connecticut. "We have more data on them than for any other animal that we eat."
Release of the analysis was slowed for years by several forces, including the dairy industry, concerned about the potential impact on exports of U.S. whey solids, foreign sales of which are growing for use as a protein supplement.
In the past month, as an announcement neared, members of Congress, led by Sen. Barbara A. Mikulski (D-Md.), sought to delay approval through legislation.
Trade-related agencies including the Foreign Agricultural Service and the Office of the U.S. Trade Representative, which for years have struggled to get countries to accept U.S. gene-altered crops, also raised red flags.
A final blitz of meetings with FDA officials last week brought grudging acquiescence, insiders said. And it is possible, sources said, that even after the risk analysis is released, there will be calls for farmers to voluntarily refrain from selling products from clones until the trade issues can be resolved.